Héroux-Devtek Inc. (TSE:HRX – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$27.90 and traded as high as C$32.15. Héroux-Devtek shares last traded at C$32.12, with a volume of 79,978 shares trading hands.
Wall Street Analyst Weigh In
Separately, TD Securities downgraded shares of Héroux-Devtek from a “buy” rating to a “sell” rating and increased their price objective for the company from C$28.00 to C$32.50 in a report on Friday, July 12th.
Check Out Our Latest Stock Report on Héroux-Devtek
Héroux-Devtek Stock Down 0.1 %
Héroux-Devtek (TSE:HRX – Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported C$0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of C$0.26 by C$0.13. Héroux-Devtek had a return on equity of 11.18% and a net margin of 7.07%. The business had revenue of C$174.00 million during the quarter, compared to analyst estimates of C$159.00 million. Research analysts anticipate that Héroux-Devtek Inc. will post 1.640041 EPS for the current fiscal year.
Héroux-Devtek Company Profile
Héroux-Devtek Inc engages in the design, development, manufacture, finishing, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company serves commercial and defence sectors of the aerospace market.
Read More
- Five stocks we like better than Héroux-Devtek
- 10 Best Airline Stocks to Buy
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Following Congress Stock Trades
- MarketBeat Week in Review – 11/4 – 11/8
- Manufacturing Stocks Investing
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Héroux-Devtek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Héroux-Devtek and related companies with MarketBeat.com's FREE daily email newsletter.